Factory best selling Paxlovid Intermediate - Other Protected Amino Acids for Disulfide bond – Gentolex

NO

Products

CAS No

Application

Key Quality Indicator

Purity

Isomer

Specific impurity

*Max1

Moisture

1

Fmoc-Cys(Acm)-OH

86060-81-3

Disulfide bond

≥99.0%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

2

Fmoc-Cys(Mmt)-OH

177582-21-7

Disulfide bond

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

3

Fmoc-Cys(4-allylbutyrate)-OH

/

Disulfide bond

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

4

Mpa(Trt)-OH

27144-18-9

End of sequence

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

5

Fmoc-Thr(tBu)-OL

189337-28-8

Octreotide

≥97.0%

≤0.3%

≤0.5%

≤1.0%

≤1.0%

6

Fmoc-D-Arg(pbf)-OH

187618-60-6

Desmopressin

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤2.0%

7

Fmoc-Gly-Gly-OH

35665-38-4

Bivalirudin

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

8

Fmoc-Gly-Gly-Gly-OH

170941-79-4

Terlipressin

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

9

Fmoc-Gly-Gly-Gly-Gly-OH

/

Bivalirudin

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

10

Fmoc-Gly-Asp(tBu)-OH

/

Bivalirudin

≥99.5%

/

≤0.15%

≤0.2%

≤1.0%

11

Boc-Cys(Trt)-OH

21947-98-8

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

12

Boc-Arg(pbf)-OH

200124-22-7

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

13

Boc-Ala-OH

15761-38-3

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

14

Boc-D-Phe-OH

18942-49-9

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

15

Boc-Gly-OH

4530-20-5

End of sequence

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

16

Boc-Lys(Boc)-OH.DCHA

15098-69-8

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

17

Boc-Ser(tBu)-OH

7738-22-9

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

18

Boc-Thr(tBu)-OH

13734-40-2

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

19

Boc-D-Ala-OH

7764-95-6

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

20

Boc-Met-OH

2488-15-5

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

21

Boc-Tyr(tBu)-OH

47375-34-8

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

22

Boc-D-Arg(pdf)-OH

187618-60-6

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

23

Boc-Asp(OtBu)-OH.DCHA

1913/12/8

End of sequence

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

24

Fmoc-HomoArg(pbf)-OH

1159680-21-3

Eptifibatide

≥98.5%

≤0.2%

/

≤0.5%

≤2.0%

25

Fmoc-Asp-OtBu

129460-09-9

Thymalfasin

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

26

Fmoc-Tyr(Me)-OH

77128-72-4

Carbetocin

≥98.5%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

27

Fmoc-Orn(Boc)-OH

109425-55-0

Atosiban

Omnipressin

Daptomycin

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤2.0%

28

Fmoc-D-Tyr(Et)-OH

162502-65-0

Atosiban

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

29

Fmoc-Asp(OAll)-OH

146982-24-3

Melanotan

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

30

Ac-Nle-OH

15891-49-3

Melanotan

≥99.0%

/

≤0.3%

≤0.3%

≤1.0%

31

Fmoc-Nle-OH

77284-32-3

Melanotan

Afamelanotide

≥99.0%

/

≤0.3%

≤0.3%

≤1.0%

32

Ac-Glu(OtBu)-OH

84192-88-1

Argireline

Acetyl octapeptide-3

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

33

Ac-β-Ala-OH·DCHA

/

Acetyl tetrapeptide-5

≥99.0%

/

≤0.3%

≤0.3%

≤1.0%

34

Fmoc-ß-Ala-OH

35737-10-1

Acetyl tetrapeptide-5

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

35

Fmoc-Hyp(tBu)-OH

122996-47-8

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

36

Fmoc-Thi-OH

130309-35-2

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

37

Fmoc-D-Tic-OH

130309-33-0

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

38

Fmoc-Oic-OH

130309-37-4

Icatibant

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

39

Boc-Sar-OH

13734-36-6

Saralasin

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

40

Fmoc-Sar-OH

77128-70-2

Saralasin

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

41

Fmoc-Tyr(SO3Na)-OH.H2O

106864-37-3

Sincalide

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

42

Fmoc-D-Asp(OtBu)-OH

112883-39-3

Daptomycin

≥98.5%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

43

Ac-Ser(tBu)-OH

77285-09-7

Afamelanotide

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%

44

Boc-HomoCys(Trt)-OH

201419-16-1

Depreotide

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

45

Fmoc-HomoCys(Trt)-OH

167015-23-8

Depreotide

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

46

Fmoc-Dab-OH

161420-87-7

Snake venom

≥99.0%

≤0.2%

≤0.3%

≤0.3%

≤1.0%